Comparison of CellSearch versus Parsortix circulating tumor cell enumeration and molecular characterization: A pilot study in metastatic prostate cancer patients
Open Access
- 5 May 2025
- journal article
- Published by Elsevier in Next Research
- Vol. 2 (2)
Abstract
No abstract availableFunding Information
- Prostate Cancer Canada (D2017-1974)
- Government of Ontario
- International Road Federation
- Lawson Health Research Institute
This publication has 46 references indexed in Scilit:
- EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasisClinical & Experimental Metastasis, 2021
- NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancerPathology - Research and Practice, 2019
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia, 2017
- A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cellsInternational Journal of Cancer, 2016
- Stromal expression of VEGF‐A and VEGFR‐2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomyThe Prostate, 2015
- Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinomaExperimental & Molecular Medicine, 2014
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Mechanisms of bone metastasis in prostate cancer: clinical implicationsBest Practice & Research Clinical Endocrinology & Metabolism, 2008
- N-cadherin switching occurs in high Gleason grade prostate cancerThe Prostate, 2005
- Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinomaThe Prostate, 2002